Methylphenidate Pill

DRUG4 trials

Sponsors

ANRS, Emerging Infectious Diseases, National Institute on Alcohol Abuse and Alcoholism (NIAAA), University of Florida

Conditions

Alcohol Use DisorderAttention Deficit Hyperactivity DisorderNormal PhysiologySubstance-Related Disorders

Early Phase 1

Methylphenidate and Response to Alcohol Cues Pilot Study

CompletedNCT06063200

University of FloridaAlcohol Use Disorder, Attention Deficit Hyperactivity Disorder

Start: 2024-03-20End: 2025-07-01Updated: 2026-02-10

Phase 1

Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI

CompletedNCT03326245

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Normal Physiology

Start: 2018-01-29End: 2024-02-08Updated: 2024-05-28

Phase 2

Methylphenidate for Cocaine Dependence

WithdrawnNCT03090269

ANRS, Emerging Infectious DiseasesSubstance-Related Disorders

Start: 2018-06-01End: 2019-03-30Updated: 2018-07-20

Methylphenidate and Response to Alcohol Cues

Not yet recruitingNCT07306078

University of FloridaAlcohol Use Disorder

Start: 2026-10-01End: 2028-08-01Target: 50Updated: 2026-08-20

Related Papers

Neural circuit selective for fast but not slow dopamine increases in drug reward.

2023-11-0810 citations